T Rowe PR Health Science-InvPRHSX
13F holders, Q2 2024 (June 30)6holders
1new positions
1sold out
$94.79avg. 13F price*
At the end of Q2 2024, 6 institutions reported holding T Rowe PR Health Science-Inv (PRHSX) in their 13F filings, unchanged from Q1 2024. 1 opened new positions and 1 sold out. The largest holders were Ethos Financial Group, LLC ($250K), Westside Investment Management, Inc. ($139K) and Coston, McIsaac & Partners ($80K).
- Company
- T Rowe PR Health Science-Inv
- CUSIP
- 741480107
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $34K |
| Exits | 1 | $56K |
All 13F filers, Q1 2024 → Q2 2024: 362 shares bought and 594 shares sold, net −232 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 6 holders
| Ethos Financial Group, LLC | 0.04% | Reduce -0.3% | 2,634 | $250K |
| Westside Investment Management, Inc. | 0.03% | No change | 1,467 | $139K |
| Coston, McIsaac & Partners | 0.03% | No change | 849 | $80K |
| ORG Partners LLC | 0.00% | New | 362 | $34K |
| Financial Gravity Asset Management, Inc. | 0.00% | No change | 99 | $9K |
| Tucker Asset Management LLC | 0.00% | No change | 27 | $3K |
"% of holder's portfolio" is PRHSX's weight in each manager's 13F, not the share of T Rowe PR Health Science-Inv the manager owns.